BRIEF

on Medacta Group SA (isin : CH0468525222)

Medacta Expands Hip Revision Platform in Europe

Medacta Group SA has announced enhancements to its Hip Revision Platform in Europe. The platform now includes a comprehensive femoral and acetabular portfolio, aiming to improve solutions for complex hip revision surgeries. Medacta emphasizes medical education programs led by Key Opinion Leaders to support surgeons in these procedures.

The M-Vizion Femoral Revision System is central to the femoral enhancements. It offers stability and versatility with options like a modular and monobloc version. For acetabular revisions, the Mpact System features advanced biomaterials for stability and bone integration, offering solutions for complex cases.

Medacta remains dedicated to hip revision research and personalized patient solutions. Their advanced technologies will be showcased at major European congresses, including those in Berlin, Rome, and Paris.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Medacta Group SA news